Published in Am Heart J on January 01, 1973
Verapamil in ischaemic heart disease--quantitative assessment by serial multistage treadmill exercise. Postgrad Med J (1976) 0.99
Drug treatment of chronic stable angina pectoris. Br Med J (1978) 0.75
Drug treatment of chronic stable angina pectoris. Br Med J (1978) 0.75
Effect of passive smoking on angina pectoris. N Engl J Med (1978) 2.17
Carbon monoxide effect on exercise-induced angina pectoris. Ann Intern Med (1973) 2.10
Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc (1998) 1.77
Effects of verapamil on myocardial performance in coronary disease. Circulation (1979) 1.50
Carbon monoxide and coronary heart disease: A review. Environ Res (1975) 1.47
Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med (1974) 1.34
Effect of carbon monoxide on exercise performance in chronic obstructive pulmonary disease. Am J Med (1977) 1.32
Carboxyhemoglobin caused by smoking nonnicotine cigarettes. Effects in angina pectoris. Circulation (1971) 1.27
Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol (1987) 1.26
Clinical characteristics of patients younger than 60 years with mitral anular calcium: comparison with age- and sex-matched control subjects. Am J Cardiol (1984) 1.22
Response of patients and physicians to mass screening for coronary risk factors. Circulation (1975) 1.19
Effect of freeway travel on angina pectoris. Ann Intern Med (1972) 1.16
Incidence of ruptured chordae tendineae in the mitral valvular prolapse syndrome: an echocardiographic study. Chest (1979) 1.15
Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients. Circulation (1974) 1.14
Diurnal variation of plasma catecholamines and systolic time intervals. Chest (1973) 1.07
Aggravation of angina pectoris by two percent carboxyhemoglobin. Am Heart J (1981) 1.06
Five-year follow-up of maximal treadmill stress test in asymptomatic men and women. Circulation (1980) 1.05
Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc (1999) 1.04
Hypertension therapy in the older adults-do we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly. J Hum Hypertens (2012) 1.04
Treadmill stress test in left ventricular hypertrophy. Chest (1973) 1.03
Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure. Am J Cardiol (1977) 1.02
Effect of prazosin vs placebo on chronic left ventricular heart failure. Circulation (1979) 1.02
Effect of carbon monoxide exposure on intermittent claudication. Circulation (1974) 1.00
Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate. Circulation (1977) 1.00
Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use. Drugs (1982) 1.00
Hemodynamics and echocardiograms before and after cardioversion of atrial fibrillation to normal sinus rhythm. Chest (1979) 0.99
Bypass graft surgery versus medical therapy of angina pectoris. Am J Cardiol (1974) 0.97
Surgical management of coronary arterial disease in the elderly. Coron Artery Dis (1998) 0.96
Changes in ventricular septal thickness during diuretic therapy. Clin Pharmacol Ther (1982) 0.95
Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris. N Engl J Med (1969) 0.94
Atrioventricular block in familial hemochromatosis treated by permanent synchronous pacemaker. Arch Intern Med (1969) 0.94
Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use. Circulation (1977) 0.94
Echocardiographic appearance of aortic valve vegetations in bacterial endocarditis due to Actinobacillus actinomycetemcomitans. J Clin Ultrasound (1977) 0.93
Management of stable angina. N Engl J Med (1973) 0.93
The high-risk angina patient. Identification by clinical features, hospital course, electrocardiography and technetium-99m stannous pyrophosphate scintigraphy. Circulation (1981) 0.93
Tobacco: a precipitating factor in angina pectoris. Ann Intern Med (1968) 0.93
Inability of the submaximal treadmill stress test to predict the location of coronary disease. Circulation (1973) 0.92
Detection of pericardial metastases by cross-section echocardiography. Circulation (1981) 0.89
Diabetes mellitus in older African-Americans, Hispanics, and whites in an academic hospital-based geriatrics practice. Coron Artery Dis (1999) 0.89
Effect of ethanol on angina pectoris. Ann Intern Med (1976) 0.89
Treatment of arrhythmias with tolamidol. Clin Pharmacol Ther (1973) 0.88
Treatment of acute arrhythmias with orally administered tolamolol. Chest (1973) 0.88
Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium. Am J Cardiol (1984) 0.88
Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris. Clin Pharmacol Ther (1975) 0.88
Anatomic and functional correlates of intercoronary collateral vessels. Am J Cardiol (1972) 0.87
Effects of marihuana and placebo marihuana smoking on hemodynamics in coronary disease. Clin Pharmacol Ther (1975) 0.87
Effect of carbon monoxide on maximal treadmill exercise. A study in normal persons. Ann Intern Med (1975) 0.87
Correlation of atrial fibrillation with presence or absence of mitral anular calcium in 604 persons older than 60 years. Am J Cardiol (1987) 0.87
External isovolumic contraction times and left ventricular ejection time-external isovolumic contraction time ratios at rest and after exercise in coronary heart disease. Circulation (1971) 0.87
Clinical and echocardiographic characteristics of patients with mitral anular calcification. Comparison with age- and sex-matched control subjects. Am J Cardiol (1983) 0.87
Warfarin use and the risk of valvular calcification. J Thromb Haemost (2009) 0.86
Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc (2000) 0.86
Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol (2001) 0.85
Effect of timolol versus propranolol on hypertension and hemodynamics. Circulation (1976) 0.85
Effects of isosorbide dinitrate on pulmonary hypertension in chronic obstructive pulmonary disease. Clin Pharmacol Ther (1979) 0.85
Echocardiographic pseudoidiopathic hypertrophic subaortic stenosis in a patient with pericardial effusion. J Clin Ultrasound (1977) 0.85
Antihypertensive and hemodynamic effects of oxprenolol versus propranolol. Clin Pharmacol Ther (1980) 0.85
Heart rate and carbon monoxide level after smoking high-, low-, and non-nicotine cigarettes. A study in male patients with angina pectoris. Ann Intern Med (1971) 0.84
Effect of timolol plus hydrochlorothiazide plus hydralazine on essential hypertension. Circulation (1978) 0.84
Five year follow-up of double Master's test, maximal treadmill stress test, and resting and postexercise apexcardiogram in asymptomatic persons. Circulation (1975) 0.84
Effect of carbon monoxide on cardiovascular disease. Prev Med (1979) 0.84
Treadmill exercise test in aortic stenosis and mitral stenosis. Chest (1975) 0.84
Sublingual isosorbide dinitrate therapy versus sublingual acebo in angina pectoris. Circulation (1970) 0.83
Smoking and coronary artery disease. Clin Geriatr Med (1996) 0.83
Electrocardiographic monitoring during coloscopy. Am J Gastroenterol (1975) 0.83
Prevalence of coronary artery disease, ischemic stroke, peripheral arterial disease, and coronary revascularization in older African-Americans, Asians, Hispanics, whites, men, and women. Am J Cardiol (1999) 0.83
Pyrophosphate myocardial imaging. Semin Nucl Med (1980) 0.83
Risk factors for coronary artery disease in old persons in an academic hospital-based geriatrics practice. Coron Artery Dis (2000) 0.82
Cardiac muscle mass during vasodilation therapy of hypertension. Clin Pharmacol Ther (1983) 0.82
Editorial: Smoking, carbon monoxide, and coronary heart disease. Circulation (1973) 0.82
Guidelines and the use of inferior vena cava filters: a review of an institutional experience. J Thromb Haemost (2008) 0.82
Calcium channel blockers: indications and limitations 2. Use in angina and other cardiac disorders. Postgrad Med (1982) 0.82
Effects of carbon monoxide on coronary heart disease. Geriatrics (1974) 0.82
Signal-averaged electrocardiography and ventricular tachycardia as predictors of mortality after acute myocardial infarction in elderly patients. Am J Cardiol (1995) 0.82
Effect of non-nicotine cigarettes and carbon monoxide on angina. Circulation (1980) 0.82
Technetium-99m stannous pyrophosphate myocardial scintigrams in pericardial disease. Am Heart J (1980) 0.81
The effect of low-nicotine cigarettes on angina pectoris. Ann Intern Med (1969) 0.81
The medical treatment of angina pectoris. VI. Propranolol as an antianginal drug. Am Heart J (1972) 0.81
Follow-up of mass screening for coronary risk factors in 1817 adults. Circulation (1975) 0.81
Isovolumic contraction and left ventricular ejection times. External measurements at rest and after exercise in normal men. Am J Cardiol (1970) 0.81
Reliability of echocardiography in quantitating pericardial effusion: a prospective study. J Clin Ultrasound (1977) 0.81
Effect of halofenate on serum uric acid. Clin Pharmacol Ther (1973) 0.81
Effect of halofenate on serum lipids. Clin Pharmacol Ther (1973) 0.80
Risk factors for coronary artery disease in persons older than 62 years in a long-term health care facility. Am J Cardiol (1986) 0.80
Long-term efficacy of halofenate on serum triglyceride levels. Curr Ther Res Clin Exp (1975) 0.80
Prevalence of arrhythmias detected by ambulatory electrocardiographic monitoring and of abnormal left ventricular ejection fraction in persons older than 62 years in a long-term health care facility. Am J Cardiol (1987) 0.80
Significance of echocardiographic left atrial enlargement in aortic stenosis. Clin Cardiol (1982) 0.80
The value of early out-patient cardiac exercise programmes for the elderly in comparison with other selected age groups. Eur Heart J (1984) 0.80
Carbon monoxide and ventricular fibrillation threshold in normal dogs. Arch Environ Health (1979) 0.80
Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease. J Am Geriatr Soc (1998) 0.80
Digitalis as an antianginal agent. Chest (1973) 0.80
Effect of cigarette smoking and of carbon monoxide on coronary heart disease. Chest (1976) 0.80
Effect of marijuana and placebo-marijuana smoking on psychological state and on psychophysiological cardiovascular functioning in anginal patients. Biol Psychiatry (1977) 0.79
Follow-up technetium-99m stannous pyrophosphate myocardial scintigrams after acute myocardial infarction. Circulation (1977) 0.79
Treatment of angina pectoris. Pharmacologic approaches. Postgrad Med (1976) 0.79
Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice. J Am Geriatr Soc (1998) 0.79
The effect of smoking cigarettes on the apexcardiogram in coronary heart disease. Chest (1971) 0.79
Verapamil in atrial fibrillation and atrial flutter. Clin Pharmacol Ther (1979) 0.79
Verapamil versus placebo in atrial fibrillation and atrial flutter. Clin Invest Med (1980) 0.79